Boston Scientific Corp (NYSE:BSX)

43.21
Delayed Data
As of Jan 24
 -0.36 / -0.83%
Today’s Change
34.35
Today|||52-Week Range
46.62
-4.44%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Fitzgerald Joseph M
Sale12/13/2019107,692$45.00$4.8M-4.17%
Mahoney Michael F
Chairman, President & Chief Executive Officer
Sale2/20/2019103,012$40.11$4.1M+7.73%
Brennan Daniel J /boston/
Chief Financial Officer & Executive Vice President
Sale3/04/201964,223$40.84$2.6M+7.22%
Mackey Edward
EVP-Operations
Sale5/01/201955,320$36.83$2.0M+18.77%
Brennan Daniel J /boston/
Chief Financial Officer & Executive Vice President
Sale3/14/201946,360$40.02$1.9M+7.89%
Fitzgerald Joseph M
Sale2/12/201944,236$40.00$1.8M+7.92%
Mahoney Michael F
Chairman, President & Chief Executive Officer
Sale1/01/202036,548$45.22$1.7M-4.68%
Nanavaty Maulik K
SVP & President-Neuromodulation
Sale8/29/201934,035$42.64$1.5M+0.86%
Mackey Edward
EVP-Operations
Sale3/11/201935,906$39.72$1.4M+8.30%
Carruthers Wendy
Senior Vice President-Human Resources
Sale3/11/201929,412$39.63$1.2M+8.30%
Page of 26